Correction of humoral derangements from mutant superoxide dismutase 1 spinal cord

Annals of Neurology

Volumn 60, Issue 6, 2006, Pages 716-728

  Kim, Yun Sook ^a   Martinez, Tara ^b   Deshpande, Deepa M ^a   Drummond, Jennifer ^a   Provost Javier, Katie ^b   Williams, Ariel ^a   McGurk, Julie ^a   Maragakis, Nicholas ^a   Song, Hongjun ^a   Ming, Guo Li ^a   Kerr, Douglas A ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SCAVENGER; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DISEASE MODEL; EMBRYONIC STEM CELL; ENZYME ACTIVITY; MOTONEURON; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ASSAY; SPINAL CORD; TISSUE CULTURE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIBODIES; CELL LINE, TRANSFORMED; CELL SURVIVAL; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; INTERLEUKINS; MALE; MICE; MICE, TRANSGENIC; MOTOR NEURONS; NERVE REGENERATION; NITRIC OXIDE; ORGAN CULTURE TECHNIQUES; SPINAL CORD; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33845988004     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21034     Document Type: Article

References (39)

1. Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;364:362.
2. Hafezparast M, Klocke R, Ruhrberg C, et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 2003;300:808-812.
3. Clement AM, Nguyen MD, Roberts EA, et al. Wild-type non-neuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003;302:113-117.
4. Boillee S, Yamanaka K, Lobsiger CS, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006;312:1389-1392.
5. Elliott JL. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 2001; 95:172-178.
6. Weydt P, Yuen EC, Ransom BR, Moller T. Increased cytotoxic potential of microglia from ALS-transgenic mice. Glia 2004;48: 179-182.
7. Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992;140:691-707.
8. Fischer LK, Culver DG, Davis AA, et al. The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse. Neurobiol Dis 2005;19:293-300.
9. Almer G, Vukosavic S, Romero N, Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999;72: 2415-2425.
10. Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and peroxynimic. Nature 1993;364:584.
11. Rothstein JD, Bristol LA, Hosler B, et al. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci U S A 1994;91:4155-4159.
12. Mayer M, Noble M. N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci U S A 1994; 91:7496-7500.
13. Friedlander RM, Brown RH, Gagliardini V, et al. Inhibition of ICF, slows ALS in mice. Nature 1997;388:31.
14. Sekizawa F, Openshaw H, Ohbo K, et al. Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and noninflammatory central nervous system diseases. J Neurol Sci 1998;154:194-199.
15. Lambrechts D, Storkebaum L, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003;34:383-394.
16. Azzonz M, Ralph GS, Storkebaum E, et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Narure 2004;429:413-417.
17. Deshpande DM, Kim YS, Martinez T, et al. Recovery from paralysis in adult rats rising embryonic stem cells. Ann Neurol 2006;60:32-44.
18. Stoppini L, Buchs PA, Muller D. A simple merhod for organotypic cultures of nervous tissue. J Neurosci Methods 1991; 37:173-182.
19. Suhr ST, Senut MC, Whitelegge JP, et al. Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J Cell Biol 2001;153:283-294.
20. Ferrari G, Yan CY, Greene LA. N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells. J Neurosci 1995;15:2857-2866.
21. Ford L, Rowe D. Interleukin-12 and interferon-gamma are not detectable in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:118-120.
22. Hall ED, Andrus PK, Oostveen JA, et al. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J Neurosci Res 1998;53:66-77.
23. Henderson JT, Javaheri M, Kopko S, Roder JC. Reduction of lower motor neuron degeneration in wobbler mice bv N-acetyl-L-cysteine. J Neurosci 1996;16:7574-7582.
24. Louwerse ES, Weverling GJ, Bossuyt PM, et al. Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol 1995;52:559-564.
25. Basu A, Krady JK, Levison SW. Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res 2004;78:151-156.
26. Li Y, Liu L, Barger SW, Griffin WS. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 2003;23:1605-1611.
27. Loddick SA, Rothwell NJ. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in local cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1996;16:932-940.
28. Raingeaud J, Gupta S, Rogers JS, et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995;270:7420-7426.
29. Masaki R, Saito T, Yamada K, Ohtani-Kaneko R. Accumulation of phosphorylated neurofilaments and increase in apoptosis-specific protein and phosphorylated c-Jun induced by proteasome inhibitors. J Neurosci Res 2000;62:75-S3.
30. Gadient RA, Otten UH. Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997;52:379-390.
31. Kaplin AI, Deshpande DM, Scott L, et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 2005;115: 2731-2741.
32. Gruol DL, Nelson TE. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997;15:307-339.
33. Campbell IL, Abraham CR, Masliah L, et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A 1993;90:10061-10065.
34. Tima M, Polat S, Erman T, et al. Effect of anti-rat interleukin-6 antibody after spinal cord injury in the rat: inducible nitric oxide synthase expression, sodium- and potassium-activated. magnesium-dependent adenosine-5′ triphosphatase and superoxide dismutase activation, and ultrastructural changes. J Neurosurg 2001;95:64-73.
35. Becher B, Dodelet V, Fedorowicz V, Antel JP. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J Clin Invest 1996;98:1539-1543.
36. Jana M, Dasgupta S, Saha RN, et al. Induction of tumor necrosis factor-alpha (TNF-alpha) by interleukin-12 p40 monomer and homodimer in microglia and macrophages. J Neurochem 2003;86:519-528.
37. Sun Y, Jin K, Xie L, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after local cerebral ischemia. J Clin Invest 2003;111:1843-1851.
38. Sun FY, Guo X. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J Neurosci Res 2005;79:180-184.
39. Murakami T, Ilieva H, Shiote M, et al. Hypoxic induction of vascular endothelial growth factor is selectively impaired in mice carrying the mutant SOD1 gene. Brain Res 2003;989:231-237.